Oculis Holding AG ( OCS) - Key Metrics
OCS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.33 | -$0.33 |
| 2026Q1 | $0 | -$0.50 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.42 | -$0.30 | -$0.30 |
| 2025Q3 | $0 | -$0.32 | -$0.25 | -$0.26 |
| 2025Q2 | $0 | -$0.49 | -$0.33 | -$0.33 |
OCS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -17.52 |
| 2026Q1 | 0% | -10.62 |
| 2025Q4 | 0% | -9.43 |
| 2025Q3 | 0% | -10.92 |
| 2025Q2 | 0% | -7.85 |
OCS
Price: $12.94
52 week price:
Earnings Per Share: -1.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Market Capitalization: 715.8 million